Screening Europe

SELECTBIO is pleased to present Screening Europe, which will Feature an array of leading international speakers. This event aims to provide you with an insight into the latest developments in screening technologies and their applications.

Hot topics to be covered include 3D cell based screening methods, the use of model organisms, and novel approaches for data analysis. Focus will also be given to the evolving use of phenotypic screening. Attending this event will provide you with excellent opportunities for networking with like minded peers, helping you to find solutions and build collaborations.

Agenda Topics:

- 3D Cell Based Assays
- High Content Screening
- Novel Approaches for Data Analysis
- Phenotypic Screening
- Use of Model Systems
+ show speakers and program
Keynote Speakers:

Lorenz M. Mayr
VP Reagents & Assay Development, AstraZeneca

David Swinney
Chief Executive Officer, Institute for Rare and Neglected Diseases Drug Discovery

Gerardo Turcatti
Director of the Biomolecular Screening Facility, Ecole Polytechnique Federale de Lausanne

Other Speakers Include:

- Jens Peter von Kries, Head of Screening, FMP/Leibniz Institute for Molecular Pharmacology
- Jani Saarela, , Institute for Molecular Medicine Finland
- Kamyar Hadian, Head of Assay Development and Screening Platform, Helmholtz Zentrum M√ľnchen
- Robin Ketteler, Group Leader, University College London
- Miguel Mano, Scientific Manager, HTS Facility, ICGEB Trieste
- Peter Horvath, Finnish Distinguished Professor (FiDiPro) Fellow, FIMM Helsinki and Group Leader, Hungarian Academia of Sciences
- Cedric Gaggioli, Baby Team Leader, IRCAN
- Neil Carragher, Principal Investigator, University of Edinburgh
- Frank Buchholz, , Max Planck Institute of Molecular Cell Biology and Genetics
- Urban Liebel, CTO, ACQUIFER
- Stephen Brown, Screening Manager, University of Sheffield

17 Feb - 18 Feb 2015

meeting website